Tempus AI, Inc, a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration with Genialis, the...
Genialis, the RNA-biomarker company, and Debiopharm, a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases,...